Stay updated on Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.

Latest updates to the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page
- Check2 days agoChange DetectedThe page now includes a consolidated 'Locations' section listing California, Florida, Illinois, Kentucky, Maryland, Michigan, and North Carolina, and the page revision updated to v3.3.3, while standalone state-specific subsections and the 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.9%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows Revision: v3.3.2 and no longer displays Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding lapse notice was removed from the page, and core study details (design, eligibility criteria, contacts, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedThe new screenshot shows updated record history with the last update posted on 2024-11-12 and the last verification date. This indicates recent maintenance of the study record.SummaryDifference0.5%

- Check82 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference5%

- Check89 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.